Latest ArticlesTucatinib(1) is an oral inhibitor of HER2 for clinical treatment of HER2- positive breast cancers. In this paper, the synthesis methods of 1 and its key intermediate 4-([1,2,4]triazolo[1,5-a]pyridin-7-yloxy)-3-methylaniline(2) are reviewed, and the advantages and disadvantages of each synthetic route are discussed. This review is beneficial to the future process research of tucatinib.
Oral administration is the preferred method for drug delivery. However, due to the unique properties of drugs and the gastrointestinal barrier, the bioavailability of oral administration is limited. By referencing the structural characteristics of organisms in nature and adopting a biomimetic perspective, the biomimetic nanocarriers can be designed and prepared to improve the oral absorption of drugs, which hold promising development prospects. This review summarizes the application of nanocarriers designed and prepared with various biomimetic ideas in oral drug delivery, offering insights and references for the development and clinical application of oral nanocarriers.
Paclitaxel belongs to the diterpenoid compounds and has good antitumor activity against various cancers such as ovarian cancer and breast cancer. Due to its poor solubility, paclitaxel has significant adverse reactions when it was used directly, limiting its clinical application. Serum albumin nanoparticles can compensate for the inherent defects of paclitaxel, enhance the stability of the drug in the body, improve its bioavailability and targeting ability, achieve the purpose of enhancing efficacy and reducing toxicity, and to some extent solve the problem of paclitaxel. This review summarizes the preparation process of serum albumin-paclitaxel nanoparticles, the application of modified serum albumin in paclitaxel-loaded nanoparticles, in order to provide theoretical guidance for the development of serum albumin based nanodrug delivery systems that meet actual clinical applications.
Surface modified liposomes with hyaluronic acid as a new transdermal drug delivery carrier can significantly improve the transdermal penetration of drugs by swelling the stratum corneum through the powerful hydration effect of hyaluronic acid. Due to its unique structure and tumor cell targeting, hyaluronic acid forms a mesh structure on the surface of liposomes, which can realize active targeting, prevent drug leakage, prolong drug release, improve stability, and synergistically enhance antitumor activity. This study mainly introduces the research progress of hyaluronic acid modified liposomes in the aspects of the preparation methods and related parameters, synergistic transdermal absorption of hyaluronic acid and liposomes, enhancement of tumor cell targeting of liposomes, the stability and sustained release effect of modified liposomes, as well as application prospects. It provides a reference for the further development of hyaluronic acid modified liposomes for transdermal drug delivery.
Cyclosporine A, a potent immunosuppressive agent, is extensively utilized in ophthalmic treatments. However, its high relative molecular mass and pronounced hydrophobicity pose challenges to its penetration through the physiological barriers of eyes, leading to low bioavailability. By strategically integrating innovative excipients and formulation technologies, the bioavailability of cyclosporine A can be enhanced from four aspects: increasing drug solubility, facilitating penetration through ocular mucus, boosting deep penetration into corneal tissues, and extending residence time on the ocular surface. This review focuses on the characteristics, action mechanisms, and associated formulation technologies of novel excipients employed in cyclosporine A ophthalmic formulations, to provide a reference for efficient delivery of cyclosporine A and the development of future novel formulations.
Tumor is closely related to the copper disorder in human body. In order to discover new copper ion chelating antitumor compounds, five 8-hydroxyquinoline derivatives were synthesized by C-2 aldol condensation, elimination and Michael reaction with 2-methyl-8-hydroxyquinoline as the starting material. The copper ion chelating ability and selectivity were studied by ultraviolet titration. And their cytotoxicity against human melanoma cells(A375 cells and Colo829 cells), human lung cancer cells(A549 cells), human liver cancer cells(HepG2 cells), human cervical cancer cells(HeLa cells) and human immortalized keratinocytes(HaCaT cells) was determined by MTT assay. Finally, two compounds TDMQ51 and TDMQ53 showed higher safety than the positive control fluorouracil(5-FU), while the complexation constants for copper and zinc differed by 13 orders of magnitude. These two compounds could be studied intensively as lead compounds owing to the good inhibitory activity to a wide variety of tumor cells.
To perform the quality control of arbidol hydrochloride, five potential related substances were synthesized. They were ethyl 6-bromo-4-[(dimethylamino)methyl]-5-hydroxy-1-methyl-2-[(phenylsulfinyl)-methyl]-1H-indole-3-carboxylate(related substance A), ethyl 6-bromo-4-[(dimethylamino)methyl]-5-hydroxy-1,2-dimethyl-1H-indole-3-carboxylate(related substance B), ethyl 6-bromo-5-hydroxy-1-methyl-4-[(methylamino)-methyl]-2-[(phenylthio)methyl]-1H-indole-3-carboxylate(related substance C), ethyl 4-[(dimethylamino)methyl]-5-hydroxy-1-methyl-2-[(phenylthio)methyl]-1H-indole-3-carboxylate(related substance D) and ethyl 6,7-dibromo-4-[(dimethylamino)methyl]-5-hydroxy-1-methyl-2-[(phenylthio)methyl]-1H-indole-3-carboxylate(related substance E). Their chemical structures were confirmed by MS, 1H NMR and 13C NMR.
The fingerprints of decoction pieces and dispensing granules of Bupleurum chinense DC. were established by HPLC coupled with evaporative light scattering detector according to the “Similarity Evaluation system of TCM Chromatographic Fingerprint(2012 edition)”. The similarity was evaluated and the common characteristic peaks were determined. Softwares of SPSS 22.0 and SIMCA 14.1 were used for cluster analysis(CA), principal component analysis(PCA) and orthogonal partial least square discriminant analysis to screen the different components that affected the quality of decoction pieces and dispensing granules. The results showed that there were twenty-four common peaks in ten batches of decoction pieces, with a similarity of no less than 0.985. And there were sixteen common peaks in twenty batches of dispensing granules, with a similarity of 0.858 - 0.998. Six common peaks were identified, including saikosaponin c(peak 6), saikosaponin f(peak 7), saikosaponin a(peak 9), saikosaponin d(peak 18), saikosaponin b2(peak 28) and saikosaponin b1(peak 29). The results of CA and PCA showed that Bupleurum chinense DC. decoction pieces and Bupleurum chinense DC. dispensing granules were clustered into two categories. The variable importance in the projection(VIP) values of sixteen common peaks were all high than 1, which meant the difference between decoction pieces and dispensing granules. The established fingerprint and chemical pattern recognition analysis method can be used to evaluate the quality of decoction pieces and dispensing granules of Bupleurum chinense DC.